TherapeuticsMD, Inc. (TXMD) Financials
TXMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 42.1 million | 13.4 million |
2023-12-31 | 43.3 million | 14.0 million |
2023-09-30 | 50.5 million | 22.4 million |
2023-06-30 | 53.7 million | 22.5 million |
TXMD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 11000 | 111000 |
2023-12-31 | -7.8 million | 116000 |
2023-09-30 | -6.0 million | 234000 |
2023-06-30 | -3.4 million | 438000 |
TXMD Net Income
No data available :(
TXMD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 4.3 million | - | 7.8 million |
2023-12-31 | 4.3 million | - | - |
2023-09-30 | 10.2 million | - | 8.2 million |
2023-06-30 | 13.7 million | - | 8.4 million |
TXMD Shares Outstanding
TXMD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | - | - | 1.3 million | - |
2023-12-31 | - | - | 3.1 million | 1.6 million |
2023-09-30 | - | - | 1.6 million | - |
2023-06-30 | 10000 | - | 2.8 million | - |
TXMD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 313000 | 133000 |
2023-12-31 | 502000 | 637000 |
2023-09-30 | -53000 | 130000 |
2023-06-30 | 437000 | 128000 |
TXMD
Price: $2.13
52 week price:
Earnings Per Share: -0.74 USD
P/E Ratio: 0.46
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 688
Ebitda: -21.6 millionMarket Capitalization: 25.6 million